Journal Article

Neuroinflammatory disease signatures in SPG11-related hereditary spastic paraplegia patients

Davis, Marie Y., Stolzer, Iris, Hübner, Christian A., Coras, Roland, Winner, Beate, Pozner, Tatyana, Riemenschneider, Markus J., Günther, Claudia, Rothhammer, Veit, Krumm, Laura, Zagha, Naime, Scherpelz, Kathryn, Kaindl, Johanna, Süß, Patrick, Khundadze, Mukhran, Baets, Jonathan, Winkler, Jürgen, Arnold, Philipp, Regensburger, Martin, Krach, Florian, Tsaktanis, Thanos, Jayadev, Suman

2024

Overview

Biallelic loss of SPG11 function constitutes the most frequent cause of complicated autosomal recessive hereditary spastic paraplegia (HSP) with thin corpus callosum, resulting in progressive multisystem neurodegeneration. While the impact of neuroinflammation is an emerging and potentially treatable aspect in neurodegenerative diseases and leukodystrophies, the role of immune cells in SPG11–HSP patients is unknown. Here, we performed a comprehensive immunological characterization of SPG11–HSP, including examination of three human postmortem brain donations, immunophenotyping of patients’ peripheral blood cells and patient-specific induced pluripotent stem cell-derived microglia-like cells (iMGL). We delineate a previously unknown role of innate immunity in SPG11–HSP. Neuropathological analysis of SPG11–HSP patient brain tissue revealed profound microgliosis in areas of neurodegeneration, downregulation of homeostatic microglial markers and cell-intrinsic accumulation of lipids and lipofuscin in IBA1 + cells. In a larger cohort of SPG11–HSP patients, the ratio of peripheral classical and intermediate monocytes was increased, along with increased serum levels of IL-6 that correlated with disease severity. Stimulation of patient-specific iMGLs with IFNγ led to increased phagocytic activity compared to control iMGL as well as increased upregulation and release of proinflammatory cytokines and chemokines, such as CXCL10. On a molecular basis, we identified increased STAT1 phosphorylation as mechanism connecting IFNγ-mediated immune hyperactivation and SPG11 loss of function. STAT1 expression was increased both in human postmortem brain tissue and in an Spg11 –/– mouse model. Application of an STAT1 inhibitor decreased CXCL10 production in SPG11 iMGL and rescued their toxic effect on SPG11 neurons. Our data establish neuroinflammation as a novel disease mechanism in SPG11–HSP patients and constitute the first description of myeloid cell/ microglia activation in human SPG11–HSP. IFNγ/ STAT1-mediated neurotoxic effects of hyperreactive microglia upon SPG11 loss of function indicate that immunomodulation strategies may slow down disease progression.

• Publisher: Springer Berlin Heidelberg,Springer Nature B.V
• Subject: Animals / Blood cells / Cell activation / Chemokines / Corpus callosum / CXCL10 protein / Disease progression / Hereditary spastic paraplegia / Humans / Immunomodulation / Inflammation / Innate immunity / Leukodystrophy / Lipids / Medicine / Medicine & Public Health / Mice / Microglia / Monocytes / Mutation / Neurodegeneration / Neurodegenerative diseases / Neuroinflammatory Diseases / Neurons - pathology / Neurosciences / Neurotoxicity / Original Paper / Paralysis / Pathology / Peripheral blood / Phagocytes / Phosphorylation / Pluripotency / Proteins - genetics / Serum levels / Spastic Paraplegia, Hereditary - genetics / Spastic Paraplegia, Hereditary - pathology / Stat1 protein / γ-Interferon